Urinary microbiota – a potential biomarker and therapeutic target for bladder cancer Free

Abstract

To identify potential biomarkers and/or therapeutic targets for bladder cancer we characterized and analysed the composition of the urinary microbiota from bladder cancer and non-cancer patients.

In this study, we collected urine samples from 29 bladder cancer patients and 26 non-cancer patients. To avoid contamination and the impact of antibiotics, urine specimens were collected in a clean manner prior to antibiotic administration. Using the amplicon-based next-generation sequencing approach, the potential determinant bacteria were estimated in a between-group comparison. The results illustrated the differences in microbiota abundance among cancer and non-cancer patients and the overall number of cases carrying these bacteria.

We found that the urine samples contained a conserved microbiota with four phyla (, , and ), which accounted for 94.4 % of bacteria in all cases. Comparing the microbiota between the bladder cancer and control group, five genera of bacteria (, , , and ) existed in all samples, but with significant intergroup differences (<0.05). The bladder cancer patients presented with a higher abundance of , while the other strains were enriched in the control group. A higher abundance of was also observed in the bladder cancer group compared to the control group.

The samples collected from the bladder cancer patients displayed a significantly different pattern relative to those from the control group. The higher abundance of observed in bladder cancer patient samples also suggests that the strain may be indicative of bladder cancer. The urinary microbiota may be a potential biomarker and therapeutic target for bladder cancer.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001058
2019-08-16
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/68/10/1471.html?itemId=/content/journal/jmm/10.1099/jmm.0.001058&mimeType=html&fmt=ahah

References

  1. Thomas-White K, Forster SC, Kumar N, Van Kuiken M, Putonti C et al. Culturing of female bladder bacteria reveals an interconnected urogenital microbiota. Nat Commun 2018; 9:1557 [View Article]
    [Google Scholar]
  2. Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K et al. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 2012; 50:1376–1383 [View Article]
    [Google Scholar]
  3. Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract--a role beyond infection. Nat Rev Urol 2015; 12:81–90 [View Article]
    [Google Scholar]
  4. Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmström P-U et al. Bladder cancer. Lancet 2016; 388:2796–2810 [View Article]
    [Google Scholar]
  5. Chen W, Zheng R, Baade PD, Zhang S, Zeng H et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66:115–132 [View Article]
    [Google Scholar]
  6. Thompson DB, Siref LE, Feloney MP, Hauke RJ, Agrawal DK. Immunological basis in the pathogenesis and treatment of bladder cancer. Expert Rev Clin Immunol 2015; 11:265–279 [View Article]
    [Google Scholar]
  7. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJM, Relman DA. The application of ecological theory toward an understanding of the human microbiome. Science 2012; 336:1255–1262 [View Article]
    [Google Scholar]
  8. Ainsworth C. Microbiome: a bag of surprises. Nature 2017; 551:S40–S41 [View Article]
    [Google Scholar]
  9. Humphries A, Daud A. The gut microbiota and immune checkpoint inhibitors. Hum Vaccin Immunother 20181–5
    [Google Scholar]
  10. Xu W, Yang L, Lee P, Huang WC, Nossa C et al. Mini-Review: perspective of the microbiome in the pathogenesis of urothelial carcinoma. Am J Clin Exp Urol 2014; 2:57–61
    [Google Scholar]
  11. Wu P, Zhang G, Zhao J, Chen J, Chen Y et al. Profiling the urinary microbiota in male patients with bladder cancer in China. Front Cell Infect Microbiol 2018; 8:167 [View Article]
    [Google Scholar]
  12. Bučević Popović V, Šitum M, Chow C-ET, Chan LS, Roje B et al. The urinary microbiome associated with bladder cancer. Sci Rep 2018; 8:12157 [View Article]
    [Google Scholar]
  13. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010; 7:335–336 [View Article]
    [Google Scholar]
  14. Joshi NA, Fass JN. 2011; Sickle: A sliding-window, adaptive, quality-based trimming tool for FastQ files (Version 1.33) [Software]. https://github.com/najoshi/sickle
  15. Nurk S, Bankevich A, Antipov D, Gurevich AA, Korobeynikov A et al. Assembling single-cell genomes and mini-metagenomes from chimeric MDA products. J Comput Biol 2013; 20:714–737 [View Article]
    [Google Scholar]
  16. Conlan S, Kong HH, Segre JA. Species-Level analysis of DNA sequence data from the NIH human microbiome project. PLoS One 2012; 7:e47075 [View Article]
    [Google Scholar]
  17. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer 2013; 13:800–812 [View Article]
    [Google Scholar]
  18. Michaud DS. Chronic inflammation and bladder cancer. Urol Oncol 2007; 25:260–268 [View Article]
    [Google Scholar]
  19. Fahmy N, Lazo-Langner A, Iansavichene AE, Pautler SE. Effect of anticoagulants and antiplatelet agents on the efficacy of intravesical BCG treatment of bladder cancer: a systematic review. Can Urol Assoc J 2013; 7:740–749 [View Article]
    [Google Scholar]
  20. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H et al. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int 2002; 68:273–280 [View Article]
    [Google Scholar]
  21. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature 2011; 474:327–336 [View Article]
    [Google Scholar]
  22. Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol 2014; 52:871–876 [View Article]
    [Google Scholar]
  23. Siddiqui H, Nederbragt AJ, Lagesen K, Jeansson SL, Jakobsen KS. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol 2011; 11:244 [View Article]
    [Google Scholar]
  24. Seow SW, Cai S, Rahmat JN, Bay BH, Lee YK et al. Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors. Cancer Sci 2010; 101:751–758 [View Article]
    [Google Scholar]
  25. Corcione S, Curtoni A, Paolucci IA, Di Perri G, De Rosa FG et al. Neurological disease may precede lymphadenopathies in Actinomyces europaeus infection. J Infect Public Health 2018; 11:592–593 [View Article]
    [Google Scholar]
  26. Klein S, Nurjadi D, Horner S, Heeg K, Zimmermann S et al. Significant increase in cultivation of Gardnerella vaginalis, Alloscardovia omnicolens, Actinotignum schaalii, and Actinomyces spp. in urine samples with total laboratory automation. Eur J Clin Microbiol Infect Dis 2018; 37:1305–1311 [View Article]
    [Google Scholar]
  27. Wang H, Altemus J, Niazi F, Green H, Calhoun BC et al. Breast tissue, oral and urinary microbiomes in breast cancer. Oncotarget 2017; 8:88122–88138 [View Article]
    [Google Scholar]
  28. Silva WA, Pinheiro AM, Jahns B, Bögli-Stuber K, Droz S et al. Breast abscess due to Actinomyces europaeus. Infection 2011; 39:255–258 [View Article]
    [Google Scholar]
  29. Sabbe LJ, Van De Merwe D, Schouls L, Bergmans A, Vaneechoutte M et al. Clinical spectrum of infections due to the newly described Actinomyces species A. turicensis, A. radingae, and A. europaeus. J Clin Microbiol 1999; 37:8–13
    [Google Scholar]
  30. Funke G, Alvarez N, Pascual C, Falsen E, Akervall E et al. Actinomyces europaeus sp. nov., isolated from human clinical specimens. Int J Syst Bacteriol 1997; 47:687–692 [View Article]
    [Google Scholar]
  31. Gupta VK, Paul S, Dutta C. Geography, ethnicity or variations in human microbiome composition and diversity. Front Microbiol 2017; 8:1162 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001058
Loading
/content/journal/jmm/10.1099/jmm.0.001058
Loading

Data & Media loading...

Supplements

Supplementary material 1

Supplementary material 2

Supplementary material 3

PDF

Supplementary material 4

Supplementary material 5

Supplementary material 6

Supplementary material 7

Supplementary material 8

Most cited Most Cited RSS feed